Long‐term follow‐up of parenteral bevacizumab in patients with recurrent respiratory papillomatosis
SA Ballestas, J Hidalgo Lopez, AM Klein… - The …, 2023 - Wiley Online Library
Objective The clinical course of recurrent respiratory papillomatosis (RRP) varies from
spontaneous remission to severe airway obstruction with wide variability in recurrence …
spontaneous remission to severe airway obstruction with wide variability in recurrence …
Parenteral bevacizumab for the treatment of severe respiratory papillomatosis in an adult population
Objectives/Hypothesis Recurrent respiratory papillomatosis (RRP) is a rare, potentially life‐
threatening, disease that impacts the voice, breathing, and quality of life of patients …
threatening, disease that impacts the voice, breathing, and quality of life of patients …
Systemic bevacizumab treatment for recurrent respiratory papillomatosis: long‐term follow‐up
R Ruiz, N Balamuth, LR Javia, KB Zur - The Laryngoscope, 2022 - Wiley Online Library
Objectives/Hypothesis Systemic bevacizumab is a new adjuvant therapy for recurrent
respiratory papillomatosis (RRP) that has shown promising preliminary results in children …
respiratory papillomatosis (RRP) that has shown promising preliminary results in children …
Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review
L Pogoda, F Ziylan, DPJ Smeeing, FG Dikkers… - European Archives of …, 2022 - Springer
Purpose To this day, there is no cure for recurrent respiratory papillomatosis (RRP). Multiple
surgical procedures are performed to achieve symptom relief and prevention of airway …
surgical procedures are performed to achieve symptom relief and prevention of airway …
Systemic bevacizumab for recurrent respiratory papillomatosis: a national survey
SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - Wiley Online Library
Objectives/Hypothesis Aggressive laryngeal, tracheal, and pulmonary papilloma is an
extremely challenging clinical problem without proven treatment options. A recent German …
extremely challenging clinical problem without proven treatment options. A recent German …
Long‐term follow‐up on systemic bevacizumab treatment in recurrent respiratory papillomatosis
G Evers, C Schliemann, A Beule, LH Schmidt… - The …, 2021 - Wiley Online Library
Objectives/Hypothesis Recurrent respiratory papillomatosis (RRP) is a primarily benign
disease affecting the entire respiratory tract. Treatment is challenging and usually involves …
disease affecting the entire respiratory tract. Treatment is challenging and usually involves …
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience
Objectives Medical therapies to limit disease recurrence are critically needed for recurrent
respiratory papillomatosis (RRP). Systemic bevacizumab is emerging as an exciting …
respiratory papillomatosis (RRP). Systemic bevacizumab is emerging as an exciting …
Efficacy of systemic bevacizumab for recurrent respiratory papillomatosis with pulmonary involvement
RJ So, JC Hidalgo Lopez, SA Ballestas… - The …, 2024 - Wiley Online Library
Objectives Pulmonary papillomatosis is a rare but severe manifestation of recurrent
respiratory papillomatosis (RRP). Efficacy data of systemic bevacizumab for pulmonary RRP …
respiratory papillomatosis (RRP). Efficacy data of systemic bevacizumab for pulmonary RRP …
Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosis
SR Best, AD Friedman… - Annals of Otology …, 2012 - journals.sagepub.com
Objectives: Increasing evidence supports the use of laryngeal injections of the
antiangiogenic agent bevacizumab (Avastin) for the adjuvant treatment of recurrent …
antiangiogenic agent bevacizumab (Avastin) for the adjuvant treatment of recurrent …
[HTML][HTML] Systemic bevacizumab for recurrent respiratory papillomatosis: a single center experience of two cases
A Bedoya, K Glisinski, J Clarke, RN Lind… - The American Journal …, 2017 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Recurrent respiratory papillomatosis (RRP),
caused by human papillomavirus (HPV), is the most common benign neoplasm of the larynx …
caused by human papillomavirus (HPV), is the most common benign neoplasm of the larynx …